BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9428001)

  • 1. Role of vascular nitric oxide in physiological and pathological conditions.
    Marín J; Rodríguez-Martínez MA
    Pharmacol Ther; 1997 Aug; 75(2):111-34. PubMed ID: 9428001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The L-arginine-nitric oxide system: physiology, physiopathology and clinical relevance].
    Garini G; Savazzi G; Borghetti A
    Recenti Prog Med; 1997 Feb; 88(2):90-9. PubMed ID: 9148375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide in cardiovascular diseases.
    Nava E; Noll G; Lüscher TF
    Ann Med; 1995 Jun; 27(3):343-51. PubMed ID: 7546624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
    Böger RH; Ron ES
    Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [NO and atherosclerosis].
    Ohtani K; Egashira K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():544-7. PubMed ID: 15506446
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular diseases and the nitric oxide pathway.
    Llorens S; Nava E
    Curr Vasc Pharmacol; 2003 Oct; 1(3):335-46. PubMed ID: 15320480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide.
    Moncada S
    J Hypertens Suppl; 1994 Dec; 12(10):S35-9. PubMed ID: 7539493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions among ACE, kinins and NO.
    Linz W; Wohlfart P; Schölkens BA; Malinski T; Wiemer G
    Cardiovasc Res; 1999 Aug; 43(3):549-61. PubMed ID: 10690327
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanism of nitric oxide production in vascular endothelium and the significance as therapeutic target--special reference to the relationship with superoxides].
    Oike M
    Fukuoka Igaku Zasshi; 2000 Oct; 91(10):256-65. PubMed ID: 11215249
    [No Abstract]   [Full Text] [Related]  

  • 10. Normal and pathological distribution of nitric oxide in the cardiovascular system.
    Malinski T
    Pol J Pharmacol; 1998; 50(6):387-91. PubMed ID: 10385920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [L-Arginine and vascular health].
    Ströhle A; von Bibra H; Hahn A
    Med Monatsschr Pharm; 2016 Dec; 39(12):515-20. PubMed ID: 29979511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The cardiovascular significance of nitric oxide].
    Artenie R; Artenie A; Cosovanu A
    Rev Med Chir Soc Med Nat Iasi; 1999; 103(3-4):48-56. PubMed ID: 10756925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial function and nitric oxide: clinical relevance.
    Vallance P; Chan N
    Heart; 2001 Mar; 85(3):342-50. PubMed ID: 11179281
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of endothelium-formed nitric oxide on vascular responses.
    Marín J; Sánchez-Ferrer CF
    Gen Pharmacol; 1990; 21(5):575-87. PubMed ID: 2276579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary endothelial dysfunction: atherosclerosis.
    Shimokawa H
    J Mol Cell Cardiol; 1999 Jan; 31(1):23-37. PubMed ID: 10072713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biology and therapeutic potential of the DDAH/ADMA pathway.
    Arrigoni F; Ahmetaj B; Leiper J
    Curr Pharm Des; 2010; 16(37):4089-102. PubMed ID: 21247398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.
    Vallance P; Leiper J
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1023-30. PubMed ID: 15105281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
    Böger RH
    Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):55-61. PubMed ID: 18090660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide and the cardiovascular system.
    Welch G; Loscalzo J
    J Card Surg; 1994 May; 9(3):361-71. PubMed ID: 8054733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
    Siasos G; Tousoulis D; Antoniades C; Stefanadi E; Stefanadis C
    Int J Cardiol; 2007 Apr; 116(3):300-8. PubMed ID: 16860889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.